Global C-Reactive Protein Testing Market Size &
Analysis - By Detection Range (HS-CRP, CCRP, Conventional CRP), By Assay Type
(ELISA, Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assay,
Others), By Disease Type (Inflammatory Bowel Disease, Endometriosis, Cancer,
Rheumatoid Arthritis, Cardiovascular Diseases, Lupus, Others), By Application
(Hospitals And Clinics, Laboratories, Assisted Living Healthcare Facilities,
Others), By Region (North America, Europe, Asia-Pacific, CSA, MEA)- Forecasts
to 2026
C-Reactive
Protein Testing Market Opportunities:
Rise in adoption of point of care
devices:
Point of care testing or bedside
testing essentially involves medical diagnostic testing near the point of care.
This kind of testing is aimed at facilitating easy, fast and convenient
diagnosis. The newest points of care devices are easy to use by patients. They
are used to monitor levels of inflammatory proteins in the patient. The paper
based tests are able to measure serum stain length inside the paper. These
tests take approximately 5 minutes to get results as opposed to lab-based CRP
tests which take several hours. Point of care testing devices use the wax
printing method to define hydrophobic boundaries, it also reduces cost involved
in manufacturing & operations. Government institutions are actively
supporting adoption of point of care devices in medical facilities and
promoting development of new technology. In July 2018, NHS England announced
that they will be introducing point of care diagnostic devices in General
practice. Use of these devices in general practice diagnostics is expected to
bring down prescription of antibiotics substantially.
Request
for a sample copy of the report @:https://www.globalmarketestimates.com/report-summary.php?report_id=1975&report_name=global-c-reactive-protein-testing-market
C-Reactive
Protein Testing Market Challenges:
Availability of
alternative tests with higher accuracy:
The major
challenge faced by the C-reactive protein market is technological advancement
and development of newer tests which provide more efficient and accurate
results. The ESR (Erythrocyte Sedimentation Rate) test is widely used as a
marker for measuring inflammation along with the CSP test. ESR is useful in
monitoring and diagnosing chronic diseases. Further, neither the CRP not ESR
test is a definitive diagnostic test to conclude the patient diagnosis. A
combination of multiple blood and physical tests are necessary to reach a
diagnosis. Due to these reasons, general practitioners and medical facilities
prefer using more advanced blood tests to improve their diagnosis and reduce
lag time. Availability of advanced tests with improved accuracy is therefore
expected to be a challenge for growth in the C-reactive protein testing market.
No comments:
Post a Comment